Public Profile

Lupin

Lupin Limited, commonly referred to as Lupin, is a prominent global player in the pharmaceutical industry, headquartered in Mumbai, India. Founded in 1968, the company has established a strong presence in key operational regions, including North America, Europe, and Asia. Lupin is renowned for its diverse portfolio, which encompasses generic and branded formulations, biotechnology products, and active pharmaceutical ingredients (APIs). With a commitment to innovation, Lupin has achieved significant milestones, including numerous approvals from regulatory authorities worldwide. The company is particularly noted for its leadership in the anti-TB and cardiovascular segments, offering unique products that cater to unmet medical needs. As a result, Lupin has secured a competitive market position, consistently ranking among the top generic pharmaceutical companies globally.

DitchCarbon Score

How does Lupin's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

41

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

22

Industry Benchmark

Lupin's score of 41 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.

94%

Lupin's reported carbon emissions

In 2023, Lupin Limited reported total carbon emissions of approximately 410,755,000 kg CO2e. This figure includes Scope 1 emissions of about 86,910,000 kg CO2e, Scope 2 emissions of approximately 323,845,000 kg CO2e, and significant Scope 3 emissions totalling around 854,936,000 kg CO2e. The company has shown a downward trend in total emissions from 2021, where emissions were about 487,676,000 kg CO2e, to 2023. Lupin has committed to near-term climate targets, although specific reduction targets have not been disclosed. The company is actively working towards improving its sustainability practices within the pharmaceuticals, biotechnology, and life sciences sector. As of now, Lupin has not committed to a net-zero target but remains focused on reducing its carbon footprint. Overall, Lupin's emissions data reflects a commitment to addressing climate change, with ongoing efforts to enhance its environmental performance in line with industry standards.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20202021202220232024
Scope 1
103,887,000
000,000,000
00,000,000
00,000,000
00,000,000
Scope 2
371,883,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
680,968,000
000,000,000
000,000,000
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Lupin's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Lupin is headquartered in IN, which has a rank of very high, indicating very high grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Lupin is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Ipca Laboratories

IN
Medical, precision and optical instruments, watches and clocks (33)
Updated 1 day ago

Wockhardt

IN
Financial intermediation services, except insurance and pension funding services (65)
Updated 6 days ago

Zydus Lifesciences

IN
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Mankind Pharma

IN
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Pfizer Limited

IN
Chemicals nec
Updated 6 days ago

Abbott India Limited

IN
Chemicals nec
Updated 29 days ago
DitchCarbon Score

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers